Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

From Starbucks Earnings Conference Call: Co. Does Not Have Adequate Capacity To Meet Growing Demand For Its Coffees

-Reuters

byBenzinga Newsdesk

May 3, 2022

1 minute read

-Reuters

Teradyne Sees Q1 2023 EPS $0.28-$0.52 Vs 0.58 Est,; Q1 2023 Revenue Of $550M-630M Vs 644.6M Est.

By Benzinga Newsdesk

Today, 10:17 AM

Guidance for the first quarter of 2023 is revenue of $550 million to $630 million, with GAAP net income of $0.26 to $0.49 per diluted share and non-GAAP net income

TER

Cowen & Co. Initiates Coverage On Absci with Market Perform Rating

By Benzinga Newsdesk

Today, 10:17 AM

Cowen & Co. analyst Doug Schenkel initiates coverage on Absci (NASDAQ:ABSI) with a Market Perform rating.

ABSI

4D Molecular’s Fabry Disease Candidate Shows Early Proof-Of-Concept

By Vandana Singh

Today, 10:17 AM

4D Molecular Therapeutics Inc (NASDAQ:FDMT) has announced interim data from the Phase 1/2 trial of intravenous 4D-310 in Fabry disease patients.…

FDMT

Tempur Sealy Q1 Earnings Tops Estimates, Cuts FY22 Outlook

By Shivani Kumaresan

Today, 10:17 AM

Tempur Sealy International Inc (NYSE:TPX) reported first-quarter FY22 sales growth of 18.7% year-on-year to $1.24 billion, beating the consensus of $1.20…

TPX

From Starbucks Earnings Conference Call: Co. Does Not Have Adequate Capacity To Meet Growing Demand For Its Coffees

Related Posts

Teradyne Sees Q1 2023 EPS $0.28-$0.52 Vs 0.58 Est,; Q1 2023 Revenue Of $550M-630M Vs 644.6M Est.

Cowen & Co. Initiates Coverage On Absci with Market Perform Rating

4D Molecular’s Fabry Disease Candidate Shows Early Proof-Of-Concept

Tempur Sealy Q1 Earnings Tops Estimates, Cuts FY22 Outlook